A designed redox-controlled caspase

Protein Science

Volumn 20, Issue 8, 2011, Pages 1421-1431

  Witkowski D, Witold A ^a   Hardy, Jeanne A ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Allostery; Apoptosis; Caspase activation; Disulfide; Engineered cysteine; Induced cell death; Loop conformation

Indexed keywords

CASPASE 7; CYSTEINE; DISULFIDE; HISTIDINE;

ARTICLE; CATALYSIS; CRYSTALLOGRAPHY; ENZYME ACTIVE SITE; ENZYME INACTIVATION; ENZYME MODIFICATION; ENZYME REACTIVATION; ENZYME STRUCTURE; IMMUNOBLOTTING; MASS SPECTROMETRY; OXIDATION; PRIORITY JOURNAL; REDUCTION;

BINDING SITES; CASPASE 7; CRYSTALLOGRAPHY, X-RAY; DISULFIDES; ESCHERICHIA COLI; MODELS, MOLECULAR; OXIDATION-REDUCTION; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS;

EID: 79960687487     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.673     Document Type: Article

References (60)

1. Orth K, Chinnaiyan AM, Garg M, Froelich CJ, Dixit VM (1996) The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J Biol Chem 271:16443-16446. (Pubitemid 26238991)
2. Fraser AG, Evan GI (1997) Identification of a Drosophila melanogaster ICE/CED-3-related protease, drICE. EMBO J 16:2805-2813. (Pubitemid 27226217)
3. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD, Wong WW (1997) Substrate specificities of caspase family proteases. J Biol Chem 272:9677-9678.
4. Eckhart L, Ban J, Fischer H, Tschachler E (2000) Caspase-14: analysis of gene structure and mRNA expression during keratinocyte differentiation. Biochem Biophys Res Commun 277:655-659.
5. Wang P, Arjona A, Zhang Y, Sultana H, Dai J, Yang L, LeBlanc PM, Doiron K, Saleh M, Fikrig E (2010) Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I. Nat Immunol 11:912-919.
6. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 272:17907-17911. (Pubitemid 27306365)
7. Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300-304. (Pubitemid 27317977)
8. Du C, Fang M, Li Y, Li L, Wang X (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33-42.
9. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z, Alnemri ES (2000) Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem 275:36152-36157.
10. Boise LH, Gonzalez-Garcìa M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608. (Pubitemid 23259741)
11. Dohlman W, Caroti M, Leflowitz R, Nathans J, Kubo T, Bonner T, Buckley N, Young A, Brann M, Julius D (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442.
12. Pop C, Chen YR, Smith B, Bose K, Bobay B, Tripathy A, Franzen S, Clark AC (2001) Removal of the pro-domain does not affect the conformation of the procaspase-3 dimer. Biochemistry 40:14224-14235. (Pubitemid 33081626)
13. Chai J, Wu Q, Shiozaki E, Srinivasula SM, Alnemri ES, Shi Y (2001) Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding. Cell 107:399-407. (Pubitemid 33049982)
14. Riedl SJ, Fuentes-Prior P, Renatus M, Kairies N, Krapp S, Huber R, Salvesen GS, Bode W (2001) Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci USA 98:14790-14795. (Pubitemid 34013923)
15. Wei Y, Fox T, Chambers SP, Sintchak J, Coll JT, Golec JM, Swenson L, Wilson KP, Charifson PS (2000) The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem Biol 7:423-432. (Pubitemid 30400045)
16. Agniswamy J, Fang B, Weber IT (2007) Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis. FEBS J 274:4752-4765. (Pubitemid 47353120)
17. Hardy JA, Wells JA (2004) Searching for new allosteric sites in enzymes. Curr Opin Struct Biol 14:706-715. (Pubitemid 39592582)
18. Hardy JA, Wells JA (2009) Dissecting an allosteric switch in caspase-7 using chemical and mutational probes. J Biol Chem 284:26063-26069.
19. Russo A, DeGraff W, Friedman N, Mitchell JB (1986) Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res 46:2845-2848. (Pubitemid 16074292)
20. Jones DP, Brown LAS, Sternberg P (1995) Variability in glutathione-dependent detoxification in vivo and its relevance to detoxication of chemical mixtures. Toxicology 105:267-274. (Pubitemid 26038248)
21. Denault JB, Drag M, Salvesen GS, Alves J, Heidt AB, Deveraux Q, Harris JL (2007) Small molecules not direct activators of caspases. Nat Chem Biol 3:519; author reply 520.
22. Peterson QP, Goode DR, West DC, Ramsey KN, Lee JJ, Hergenrother PJ (2009) PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition. J Mol Biol 388:144-158.
23. Putt KS, Chen GW, Pearson JM, Sandhorst JS, Hoagland MS, Kwon JT, Hwang SK, Jin H, Churchwell MI, Cho MH, Doerge DR, Helferich WG, Hergenrother PJ (2006) Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat Chem Biol 2:543-550. (Pubitemid 44413237)
24. Wolan DW, Zorn JA, Gray DC, Wells JA (2009) Small-molecule activators of a proenzyme. Science 326:853-858.
25. Witkowski WA, Hardy JA (2009) L20 loop is critical for caspase-7 active site formation. Protein Sci 18:1459-1468.
26. Sowdhamini R, Srinivasan N, Shoichet B, Santi DV, Ramakrishnan C, Balaram P (1989) Stereochemical modeling of disulfide bridges. Criteria for introduction into proteins by site-directed mutagenesis. Protein Eng 3:95-103.
27. Boucher D, Blais V, Drag M, Denault JB (2011) Molecular determinants involved in activation of caspase 7. Biosci Rep 31:283-294.
28. Lesort M, Lee M, Tucholski J, Johnson GVW (2003) Cystamine inhibits caspase activity. J Biol Chem 278:3825-3830.
29. Weik M, Ravelli RB, Kryger G, McSweeney S, Raves ML, Harel M, Gros P, Silman I, Kroon J, Sussman JL (2000) Specific chemical and structural damage to proteins produced by synchrotron radiation. Proc Natl Acad Sci USA 97:623-628. (Pubitemid 30070359)
30. Hardy JA, Lam J, Nguyen JT, O'Brien T, Wells JA (2004) Discovery of an allosteric site in the caspases. Proc Natl Acad Sci USA 101:12461-12466. (Pubitemid 39122046)
31. Romanowski MJ, Scheer JM, O'Brien T, McDowell RS (2004) Crystal structures of a ligand-free and malonate-bound human caspase-1: implications for the mechanism of substrate binding. Structure (Camb) 12:1361-1371. (Pubitemid 39092081)
32. Podobnik M, Kuhelj R, Turk V, Turk D (1997) Crystal structure of the wild-type human procathepsin B at 2.5 A resolution reveals the native active site of a papain-like cysteine protease zymogen1. J Mol Biol 271:774-788. (Pubitemid 27376053)
33. StrajblM, Florian J,Warshel A (2001) Ab initio evaluation of the free energy surfaces for the general base/acid catalyzed thiolysis of formamide and the hydrolysis of methyl thiolformate: a reference solution reaction for studies of cysteine proteases. J Phys ChemB 105:4471-4484.
34. Chai J, Shiozaki E, Srinivasula SM, Wu Q, Dataa P, Alnemri ES, Shi Y (2001) Structural basis of caspase-7 inhibition by XIAP. Cell 104:769-780. (Pubitemid 32241026)
35. SeegerMA, Von Ballmoos C,Eicher T, Brandstotter L,Verrey F, Diederichs K, Pos KM (2008) Engineered disulfide bonds support the functional rotationmechanismof multidrug efflux pumpAcrB.Nat Struct Mol Biol 15:199-205.
36. Ma K, Temiakov D, Anikin M, McAllister WT (2005) Probing conformational changes in T7 RNA polymerase during initiation and termination by using engineered disulfide linkages. Proc Natl Acad Sci USA 102:17612-17617. (Pubitemid 41803545)
37. Jeong MY, Kim S, Yun CW, Choi YJ, Cho SG (2007) Engineering a de novo internal disulfide bridge to improve the thermal stability of xylanase from Bacillus stearothermophilus No. 236. J Biotechnol 127:300-309. (Pubitemid 46107140)
38. Mitchinson C, Wells JA (1989) Protein engineering of disulfide bonds in subtilisin BPN. Biochemistry 28:4807-4815. (Pubitemid 19151061)
39. Falcon CM, Swint-Kruse L, Matthews KS (1997) Designed disulfide between N-terminal domains of lactose repressor disrupts allosteric linkage. J Biol Chem 272:26818.
40. Qureshi SH, Yang L, Manithody C, Iakhiaev AV, Rezaie AR (2009) Mutagenesis studies toward understanding allostery in thrombin. Biochemistry 48:8261-8270.
41. Shandiz AT, Capraro BR, Sosnick TR (2007) Intramolecular cross-linking evaluated as a structural probe of the protein folding transition state. Biochemistry 46:13711-13719. (Pubitemid 350223899)
42. Lee JK, Prussia A, Snyder JP, Plemper RK (2007) Reversible inhibition of the fusion activity of measles virus F protein by an engineered intersubunit disulfide bridge. J Virol 81:8821.
43. Muslin EH, Li D, Stevens FJ, Donnelly M, Schiffer M, Anderson LE (1995) Engineering a domain-locking disulfide into a bacterial malate dehydrogenase produces a redox-sensitive enzyme. Biophys J 68:2218-2223.
44. Shimaoka M, Lu C, Palframan RT, Von Andrian UH, McCormack A, Takagi J, Springer TA (2001) Reversibly locking a protein fold in an active conformation with a disulfide bond: integrin L I domains with high affinity and antagonist activity in vivo. Proc Natl Acad Sci USA 98:6009-6014. (Pubitemid 32488184)
45. Tomishige M, Vale RD (2000) Controlling kinesin by reversible disulfide cross-linking. Identifying the motility-producing conformational change. J Cell Biol 151:1081-1092.
46. Zheng M, Aslund F, Storz G (1998) Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 279:1718.
47. Ganesan R, Mittl PR, Jelakovic S, Grutter MG (2006) Extended substrate recognition in caspase-3 revealed by high resolution X-ray structure analysis. J Mol Biol 359:1378-1388. (Pubitemid 43922445)
48. Walters J, Pop C, Scott FL, Drag M, Swartz P, Mattos C, Salvesen GS, Clark AC (2009) A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis. Biochem J 424:335-345.
49. Singh R, Lillard JW Jr (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86:215-223.
50. Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM, Salvesen GS (1997) Target protease specificity of the viral serpin CrmA. J Biol Chem 272:7797-7800.
51. Vaidya S, Velazquez-Delgado EM, Abbruzzese G, Hardy JA (2011) Substrate-induced conformational changes occur in all cleaved forms of caspase-6. J Mol Biol 406:75-91.
52. Stennicke HR, Salvesen GS (1999) Caspases: preparation and characterization. Methods 17:313-319. (Pubitemid 29440606)
53. Cleland W (1964) Dithiothreitol, a new protective reagent for SH groups. Biochemistry 3:480-482.
54. Millis KK, Weaver KH, Rabenstein DL (1993) Oxidation/reduction potential of glutathione. J Org Chem 58: 4144-4146.
55. Kabsch W (2010) XDS. Acta Crystallogr D: Biol Crystallogr 66:125-132.
56. Collaborative Computational Project N (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D: Biol Crystallogr 50:760-763.
57. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326. (Pubitemid 27085611)
58. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ (2007) Phaser crystallographic software. J Appl Crystallogr 40:658-674. (Pubitemid 47080256)
59. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D: Biol Crystallogr 66:486-501.
60. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-ikelihood method. Acta Crystallogr D: Biol Crystallogr 53:240-255. (Pubitemid 27235885)